Compound Detail
CHEMBL4216921
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC.CO[C@H]1/C=C/C=C/C=C/C[C@H](O)[C@H](C)[C@@H](OC(=O)[C@@H](C)NC(=O)CC(C)C)/C(C)=C\CCc2cc(O)cc(c2)NC(=O)C1
Basic Information
| ChEMBL ID | CHEMBL4216921 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MEVVKVOPMKGYRK-OMQGOSEYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
626.8
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.08
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| BV-2 | IC50 | = | 8300.0 | nM | 5.08 | Inhibition of LPS-induced nitric oxide production in mouse BV2 cells after 24 hr... | 30132670 |
| PC-3 | IC50 | = | 11900.0 | nM | 4.92 | Cytotoxicity against human PC3 cells after 72 hrs by sulforhodamine B assay | 30132670 |
| HepG2 | IC50 | = | 20500.0 | nM | 4.69 | Cytotoxicity against human HepG2 cells after 72 hrs by sulforhodamine B assay | 30132670 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30132670 | 10.1021/acs.jnatprod.8b00203 | BV-2 | 2 |
| 30132670 | 10.1021/acs.jnatprod.8b00203 | HepG2 | 1 |
| 30132670 | 10.1021/acs.jnatprod.8b00203 | PC-3 | 1 |
Data from ChEMBL 36 via Core Engine